About: Community-acquired pneumonia in children()

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Community-acquired pneumonia in children() Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
title	Community-acquired pneumonia in children()
Creator	Esposito, Susanna Cardinale, Fabio Cappiello, Anna Mastrototaro, Maria Pignatelli, Mariacristina
source	Elsevier; Medline; PMC
abstract	Community-acquired pneumonia (CAP) remains a frequent cause of morbidity and mortality worldwide even in industrialised countries, and its incidence is highest among children aged < 5 years. Over the last two years, three international guidelines have been updated with new evidence concerning the incidence, aetiology and management of childhood CAP, but there are still some major problems in standardisation. The main aim of this review is to consider the available data concerning the aetiology, diagnosis, evaluation of severity, and treatment of paediatric CAP. Analysis of the literature shows that there are a number of unanswered questions concerning the management of CAP, including its definition, the absence of a paediatric CAP severity score, the difficulty of identifying its aetiology, the emergence of resistance of the most frequent respiratory pathogens to the most widely used anti-infectious agents, and the lack of information concerning the changes in CAP epidemiology following the introduction of vaccines against respiratory pathogens. More research is clearly required in various areas, and further efforts are needed to increase vaccination coverage with the already available vaccines in order to reduce the occurrence of the disease.
has issue date	2013-08-17(xsd:dateTime)
bibo:doi	10.1016/j.earlhumdev.2013.07.023
bibo:pmid	23962481
has license	no-cc
sha1sum (hex)	f1ea457b2234c16c7a1d53cb481dc0d884b98875
schema:url	https://doi.org/10.1016/j.earlhumdev.2013.07.023
resource representing a document's title	Community-acquired pneumonia in children()
has PubMed Central identifier	PMC7172476
has PubMed identifier	23962481
schema:publication	Early Hum Dev
resource representing a document's body	covid:f1ea457b2234c16c7a1d53cb481dc0d884b98875#body_text
is schema:about of	named entity 'respiratory' named entity 'diagnosis' named entity 'areas' named entity 'aetiology' named entity 'updated' named entity 'score' named entity 'aetiology' named entity 'Community-acquired pneumonia' named entity 'aetiology' named entity 'coverage' named entity 'aetiology' named entity 'morbidity' named entity 'CAP' named entity 'aetiology' named entity 'influenza infection' named entity 'patient outcomes' named entity 'aminopenicillin' named entity 'CAP' named entity 'chest radiography' named entity '95% CI' named entity 'CAP' named entity 'urine' named entity 'serotypes' named entity 'viruses' named entity 'gold standard' named entity 'CAP' named entity 'microbial' named entity 'CAP' named entity '95% confidence interval' named entity 'cyanosis' named entity 'bronchoalveolar lavage' named entity 'CAP' named entity 'CAP' named entity 'CAP' named entity 'respiratory distress' named entity 'serum' named entity 'CAP' named entity 'aetiology' named entity 'CAP' named entity 'infection' named entity 'CAP' named entity 'CAP' named entity 'infectious diseases' named entity 'radiation exposure' named entity 'parapneumonic effusions' named entity 'CAP' named entity 'industrialised countries' named entity 'chest radiography' named entity 'enzyme assays' named entity 'first-line treatment' named entity 'North America' named entity 'CT scan' named entity 'viral pneumonia' named entity 'signs and symptoms' named entity 'pathogens' named entity 'nasopharyngeal' named entity 'CAP' named entity 'pathogens' named entity 'etiological' named entity 'CAP' named entity 'antibiotics' named entity 'M. pneumoniae' named entity 'chest X-ray' named entity 'first-line' named entity 'H. influenzae' named entity 'CAP' named entity 'CAP' named entity 'cold-reacting antibodies' named entity 'atypical bacteria' named entity 'aetiology' named entity 'antibiotics' named entity 'Molecular methods' named entity 'IgM' named entity 'antigens' named entity 'PCR-based' named entity 'antimicrobial resistance' named entity 'macrolide'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software